These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 9135695

  • 21. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M, Kraljić I.
    Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
    [Abstract] [Full Text] [Related]

  • 22. Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival.
    Inman BA, Harel F, Audet JF, Meyer F, Douville P, Fradet Y, Lacombe L.
    Eur Urol; 2005 May; 47(5):695-702. PubMed ID: 15826765
    [Abstract] [Full Text] [Related]

  • 23. alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.
    Fukushima K, Satoh T, Baba S, Yamashita K.
    Glycobiology; 2010 Jan; 20(4):452-60. PubMed ID: 20008118
    [Abstract] [Full Text] [Related]

  • 24. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG, Carvahal GF, Mager DE, Haberer B, Catalona WJ.
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [Abstract] [Full Text] [Related]

  • 25. Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia.
    Sciarra A, Gentile V, Monti S, Dattilo C, Autran Gomez A, Salciccia S, Pannunzi LP, Toscano V, Di Silverio F.
    Urol Int; 2008 Nov; 80(1):68-73. PubMed ID: 18204237
    [Abstract] [Full Text] [Related]

  • 26. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
    Safarinejad MR, Shafiei N, Safarinejad S.
    Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
    [Abstract] [Full Text] [Related]

  • 27. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer; 2005 Jan 01; 103(1):76-84. PubMed ID: 15540247
    [Abstract] [Full Text] [Related]

  • 28. The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan.
    Egawa S, Soh S, Ohori M, Uchida T, Gohji K, Fujii A, Kuwao S, Koshiba K.
    Cancer; 1997 Jan 01; 79(1):90-8. PubMed ID: 8988731
    [Abstract] [Full Text] [Related]

  • 29. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK, Han BK, Jeong JS, Jeong SJ, Moon KH, Byun SS, Lee SE.
    Asian J Androl; 2008 Mar 01; 10(2):207-13. PubMed ID: 18097534
    [Abstract] [Full Text] [Related]

  • 30. Serum keratinocyte growth factor measurement in patients with prostate cancer.
    Mehta PB, Robson CN, Neal DE, Leung HY.
    J Urol; 2000 Dec 01; 164(6):2151-5. PubMed ID: 11061946
    [Abstract] [Full Text] [Related]

  • 31. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.
    Coakley FV, Chen I, Qayyum A, Westphalen AC, Carroll PR, Hricak H, Chen MH, Kurhanewicz J.
    BJU Int; 2007 Jan 01; 99(1):41-5. PubMed ID: 17227490
    [Abstract] [Full Text] [Related]

  • 32. Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia.
    Marks LS, Dorey FJ, Rhodes T, Shery ED, Rittenhouse H, Partin AW, deKernion JB.
    J Urol; 1996 Sep 01; 156(3):1035-9. PubMed ID: 8709302
    [Abstract] [Full Text] [Related]

  • 33. [Protein of type 1 binding insulin-like growth factors in blood serum in cancer and prostatic adenoma].
    Morozov AP, Trapeznikov MF, Kushlinskiĭ NE.
    Urologiia; 2007 Sep 01; (2):50-3. PubMed ID: 17580387
    [Abstract] [Full Text] [Related]

  • 34. [The effect of acute urinary retention on serum prostate specific antigen concentration].
    Hua LX, Wu HF, Sui YG, Cheng SG, Xu ZQ.
    Zhonghua Nan Ke Xue; 2002 Sep 01; 8(2):134-5. PubMed ID: 12479031
    [Abstract] [Full Text] [Related]

  • 35. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M, Jung K, Elgeti U, Brux B, Sinha P, Schnorr D, Loening SA.
    Anticancer Res; 2000 Sep 01; 20(6D):4997-5001. PubMed ID: 11326657
    [Abstract] [Full Text] [Related]

  • 36. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
    Gao ZW, Liu G, Sheng BW.
    Ai Zheng; 2004 Jun 01; 23(6):701-3. PubMed ID: 15191675
    [Abstract] [Full Text] [Related]

  • 37. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J, Högstedt B.
    Scand J Urol Nephrol; 2002 Jun 01; 36(5):330-8. PubMed ID: 12487736
    [Abstract] [Full Text] [Related]

  • 38. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
    Bhuiyan AK, Kibria SA, Subhan SS.
    Bangladesh Med Res Counc Bull; 2004 Aug 01; 30(2):51-9. PubMed ID: 15813483
    [Abstract] [Full Text] [Related]

  • 39. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 40. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men.
    Shannon BA, Cohen RJ, Garrett KL.
    BJU Int; 2008 Feb 15; 101(4):429-35. PubMed ID: 17850358
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.